U.S. market Closed. Opens in 11 hours 18 minutes

VCYT | Veracyte, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for VCYT we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is on medium level and Health is strong.

Valuation (17%)

Company Industry
P/E Ratio (TTM) -46.62 -16.22
PEG Ratio (TTM) -1.32 -1.41
P/S Ratio (TTM) 6.33 48.82
P/B Ratio (TTM) 2.22 21.13
P/FCF Ratio (TTM) 63.01 9.38
Price to 5YR AVG Earnings Ratio -44.74 -0.21
Price to 5YR AVG FCF Ratio -567.32 -7.10

Profitability (0%)

Company Industry
ROA (TTM) -4.38% -3.10%
ROE (TTM) -4.97% 24.21%
Net Profit Margin (TTM) -13.52% -1,069.78%
ROIC 5YR AVG -6.41% 16.50%

Growth (58%)

4QTR AVG 3YR AVG 5YR AVG
EPS 64.41% -36.62% -31.16%
Revenue 6.38% 38.43% 34.42%
Net Income 63.25% -66.65% -50.37%
Cash Flow 66.74% -116.66% 52.15%

Health (63%)

Company Industry
Current Ratio (TTM) 4.44 5.75
Quick Ratio (TTM) 4.17 5.47
D/E Ratio (TTM) 0.02 -15.13
Interest Coverage (TTM) -6,536.80 3.59
Piotroski F-Score 5 5
Altman Z-Score 14.80 13.47
LTL to 5YR AVG FCF -1.69 0.20
Shares Outstanding Growth 5YR AVG 14.89% 118.86%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙